Yang CH, Liu NT, Huang TW. Role of positron emission tomography in primary carcinoma ex pleomorphic adenoma of the bronchus: A case report. World J Clin Cases 2021; 9(12): 2811-2815 [PMID: 33969063 DOI: 10.12998/wjcc.v9.i12.2811]
Corresponding Author of This Article
Tsai-Wang Huang, PhD, Associate Professor, Attending Doctor, Chief Doctor, Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, No. 325 Section 2 Cheng-Kung Road, Taipei 114, Taiwan. chi-wang@yahoo.com.tw
Research Domain of This Article
Surgery
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Clin Cases. Apr 26, 2021; 9(12): 2811-2815 Published online Apr 26, 2021. doi: 10.12998/wjcc.v9.i12.2811
Role of positron emission tomography in primary carcinoma ex pleomorphic adenoma of the bronchus: A case report
Cheng-Hsi Yang, Nien-Tzu Liu, Tsai-Wang Huang
Cheng-Hsi Yang, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan
Nien-Tzu Liu, Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan
Tsai-Wang Huang, Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, Taipei 114, Taiwan
Author contributions: Yang CH collected the clinical information, reviewed the references, and wrote the manuscript; Liu NT provided the pathologic analysis; Huang CW supervised the whole work and provided consultation.
Informed consent statement: Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
Conflict-of-interest statement: To the best of our knowledge, the named authors have no conflict of interest, financial or otherwise.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Tsai-Wang Huang, PhD, Associate Professor, Attending Doctor, Chief Doctor, Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, No. 325 Section 2 Cheng-Kung Road, Taipei 114, Taiwan. chi-wang@yahoo.com.tw
Received: September 9, 2020 Peer-review started: September 9, 2020 First decision: December 14, 2020 Revised: December 27, 2020 Accepted: February 22, 2021 Article in press: February 22, 2021 Published online: April 26, 2021
Abstract
BACKGROUND
Primary carcinoma ex pleomorphic adenoma arising from the tracheobronchial system is rarely reported.
CASE SUMMARY
We present a patient with primary carcinoma ex pleomorphic adenoma of the bronchus and review the associated literature for further comparison, including age, clinical manifestations, and diagnostic process. This patient had no history of neoplasms of the salivary gland.
CONCLUSION
Positron emission tomography played an important role in the staging work-up of primary carcinoma of ex pleomorphic adenoma. Long-term follow-up was necessary for further prognosis analysis.
Core Tip: Positron emission tomography plays an important role in defining the size of the malignant component of primary carcinoma ex pleomorphic adenoma and affects its clinical staging.
